Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawn

Garenoxacin mesylate(garenoxacin mesylate)

Surgical Wound Infection;Sinusitis;Skin Diseases, Infectious;Pneumonia;Soft Tissue Infections;Bronchitis, Chronic

Marketing Authorisation Holder: Schering-Plough Europe

INN: garenoxacin mesylate

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Garenoxacin mesylate — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.